{"id":2979,"date":"2020-11-24T19:12:19","date_gmt":"2020-11-24T19:12:19","guid":{"rendered":"https:\/\/event.roseliassociates.com\/brain-connectivity-workshop\/?page_id=2979"},"modified":"2023-09-28T13:22:53","modified_gmt":"2023-09-28T13:22:53","slug":"agenda","status":"publish","type":"page","link":"https:\/\/event.roseliassociates.com\/antibeta2023\/agenda\/","title":{"rendered":"Agenda"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"2979\" class=\"elementor elementor-2979\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-80532d8 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"80532d8\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e06bafd\" data-id=\"e06bafd\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-592b4e7 elementor-widget elementor-widget-spacer\" data-id=\"592b4e7\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-fa85a88 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"fa85a88\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e2526c8\" data-id=\"e2526c8\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-94126a9 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"94126a9\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e311a44\" data-id=\"e311a44\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-06e96e5 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"06e96e5\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-acafd9a\" data-id=\"acafd9a\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-9e3f1d1 elementor-widget elementor-widget-text-editor\" data-id=\"9e3f1d1\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><b style=\"text-align: justify\">Goal of Workshop<\/b><span style=\"text-align: justify;font-size: 12pt\">: This NINDS\/NIA sponsored workshop brings together leading experts and researchers from around the world to discuss the latest advancements and challenges in the field of anti-beta amyloid passive immunotherapy.<\/span><\/p><p>All times are Eastern Standard (EST).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-374193c elementor-widget elementor-widget-text-editor\" data-id=\"374193c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"text-decoration: underline\"><span style=\"color: #3366ff\"><a style=\"color: #3366ff;text-decoration: underline\" href=\"https:\/\/event.roseliassociates.com\/antibeta2023\/wp-content\/uploads\/sites\/72\/2023\/08\/ARIA_Agenda-Sept-28-2023.pdf\" target=\"_blank\" rel=\"noopener\">Click here to download the printable agenda.<\/a><\/span><\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-8057a2e elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"8057a2e\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1a587db\" data-id=\"1a587db\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8eb523f elementor-widget elementor-widget-heading\" data-id=\"8eb523f\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-large\">DAY 1 - <i>September 28, 2023<\/i><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8afd572 elementor-widget elementor-widget-text-editor\" data-id=\"8afd572\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><style>\ntd { vertical-align: top;}<br \/><\/style><\/p><table><tbody><tr><td width=\"208\"><strong>8:30 am<\/strong><\/td><td colspan=\"2\" width=\"208\"><strong>Welcome<\/strong><\/td><td width=\"25%\">Francesca Bosetti<br \/><em>NINDS<\/em><\/td><\/tr><tr><td width=\"208\"><strong>8:35 am<\/strong><\/td><td colspan=\"2\" width=\"208\"><strong>Introduction<\/strong><\/td><td width=\"208\">Walter Koroshetz<br \/><em>NINDS<\/em><\/td><\/tr><tr><td width=\"208\"><strong>Session 1 <\/strong><\/td><td colspan=\"2\" width=\"208\"><p><strong>Clinical Overview<\/strong><br \/><span style=\"text-decoration: underline;\">Moderators:<\/span><br \/>Steve Greenberg<br \/><em>Massachusetts General Hospital<\/em><br \/>Stephen Salloway<br \/><em>Brown University<\/em><br \/>Rod Corriveau<br \/><em>NINDS<\/em><\/p><\/td><td width=\"208\"><strong><em>\u00a0<\/em><\/strong><\/td><\/tr><tr><td width=\"208\"><strong>8:45 am<\/strong><\/td><td colspan=\"2\" width=\"208\">Overview of anti-amyloid immunotherapy for Alzheimer\u2019s dementia<\/td><td width=\"208\">David Clifford<br \/><em>Washington University<\/em><\/td><\/tr><tr><td width=\"208\"><strong>9:05 am<\/strong><\/td><td colspan=\"2\" width=\"208\">What is known about Amyloid-related imaging abnormalities (ARIA)- E and ARIA- H?<\/td><td width=\"208\">Reisa Sperling<br \/><em>Massachusetts General <\/em><br \/><em>Hospital<\/em><\/td><\/tr><tr><td width=\"208\"><strong>9:25 am<\/strong><\/td><td colspan=\"2\" width=\"208\">Lessons learned from CAA-related inflammation<\/td><td width=\"208\">Steven Greenberg<br \/><em>Massachusetts General <\/em><br \/><em>Hospital<\/em><\/td><\/tr><tr><td width=\"208\"><strong>9:45 am<\/strong><\/td><td colspan=\"2\" width=\"208\">Neuropathological studies in patients treated with anti-beta amyloid antibodies with ARIA<\/td><td width=\"208\">James Nicoll<br \/><em>University of Southampton, UK &#8211; VIRTUAL<\/em><\/td><\/tr><tr><td width=\"208\"><strong>10:05<\/strong> <strong>am<\/strong><\/td><td colspan=\"2\" width=\"208\">Advanced methods for BBB imaging<\/td><td width=\"208\">John Detre<br \/><em>University of Pennsylvania<\/em><\/td><\/tr><tr><td width=\"208\"><strong>10:25 am<\/strong><\/td><td colspan=\"2\" width=\"208\">Lessons learned from clinical trials: Identification and clinical management of patients at risk for adverse events related to ARIA<\/td><td width=\"208\">Karen Smirnakis<br \/><em>Biogen<\/em><\/td><\/tr><tr><td width=\"208\"><strong>10:45 am<\/strong><\/td><td colspan=\"2\" width=\"208\"><strong>Break <\/strong><\/td><td width=\"208\"><strong>\u00a0<\/strong><\/td><\/tr><tr><td width=\"208\"><strong>11:00 am<\/strong><\/td><td colspan=\"2\" width=\"208\"><strong>Panel Discussion<\/strong><br \/>Moderator: Clinton Wright (NINDS)<\/td><td width=\"208\"><p><span style=\"text-decoration: underline;\">Panelists:<\/span><br \/>Anand Viswanathan<br \/><em>MGH<\/em><br \/>Susan Catalano<br \/><em>Capsida Biotherapeutics<\/em><br \/>Michael Irizarry <br \/><em>Eisai<\/em><br \/>Shari Ling<br \/><em>CMS<\/em><\/p><\/td><\/tr><tr><td width=\"208\"><strong>Session 2<\/strong><\/td><td colspan=\"2\" width=\"208\"><strong>Basic Mechanisms Overview<\/strong><br \/><span style=\"text-decoration: underline;\">Moderators:<\/span><br \/>Mark Fisher<br \/><em>University of California, Irvine<\/em><br \/>Donna Wilcock<br \/><em>Indiana University<\/em><br \/>Rod Corriveau<br \/><em>NINDS<\/em><\/td><td width=\"208\"><strong><em>\u00a0<\/em><\/strong><\/td><\/tr><tr><td width=\"208\"><strong>11:40 pm<\/strong><\/td><td colspan=\"2\" width=\"208\">Cerebral Amyloid Angiopathy, Microvascular Disease, and Microhemorrhage<\/td><td width=\"208\">Mark Fisher<br \/><em>University of California, Irvine<\/em><\/td><\/tr><tr><td width=\"208\"><strong>12:00 pm<\/strong><\/td><td colspan=\"2\" width=\"208\">CAA and neurovascular dysfunction: role of innate immunity and ApoE4\u2013<\/td><td width=\"208\">Costantino Iadecola<br \/><em>Cornell University<\/em><\/td><\/tr><tr><td width=\"208\"><strong>12:20 pm<\/strong><\/td><td colspan=\"2\" width=\"208\"><strong>Lunch Break <\/strong><em>(on your own)<\/em><\/td><td width=\"208\"><strong>\u00a0<\/strong><\/td><\/tr><tr><td width=\"208\"><strong>1:15 pm<\/strong><\/td><td colspan=\"2\" width=\"208\">Blood-Brain Barrier breakdown and other vascular compromise that can occur when anti-beta-amyloid passive immunotherapy is used: Basic Disease-related science of ARIA and Basic mechanisms of BBB breakdown in ARIA.<\/td><td width=\"208\">Donna Wilcock<br \/><em>Indiana University<\/em><\/td><\/tr><tr><td width=\"208\"><strong>1:35 pm<\/strong><\/td><td colspan=\"2\" width=\"208\"><strong>Panel Discussion<\/strong><br \/><span style=\"text-decoration: underline;\">NIH Moderator:<\/span><br \/>Lanier Heyburn<br \/><em>NINDS<\/em><\/td><td width=\"208\"><span style=\"text-decoration: underline;\">Panelists:<\/span><br \/>Gary Rosenberg<br \/><em>University of New Mexico<\/em><br \/>Helene Benveniste<br \/><em>Yale University<\/em><br \/>Thierry Bussiere<br \/><em>Biogen<\/em><\/td><\/tr><tr><td width=\"208\"><strong>2:15 \u2013 2:30 pm<\/strong><\/td><td colspan=\"2\" width=\"208\"><strong>Break<\/strong><\/td><td width=\"208\"><strong>\u00a0<\/strong><\/td><\/tr><tr><td width=\"208\"><strong>Session 3<\/strong><\/td><td colspan=\"2\" width=\"208\"><strong>Future Research Ideas and Preclinical Research Ideas<\/strong><br \/><span style=\"text-decoration: underline;\">Moderators:<\/span><br \/>Katerina Akassoglou<br \/><em>Gladstone Institute, UCSF<\/em><br \/>Costantino Iadecola<br \/><em>Cornell<\/em><br \/>Linda McGavern<br \/><em>NINDS<\/em><\/td><\/tr><tr><td width=\"208\"><strong>2:30 pm<\/strong><\/td><td colspan=\"2\" width=\"208\">What Animal models would be useful in understanding CAA and ARIA.<\/td><td width=\"208\">William Van Nostrand<br \/><em>Univ. Rhode Island &#8211; VIRTUAL<\/em><\/td><\/tr><tr><td width=\"208\"><strong>2:50 pm<\/strong><\/td><td colspan=\"2\" width=\"208\">Nonhuman primate models of CAA and ARIA<\/td><td width=\"208\">Lary Walker<br \/><em>Emory University<\/em><\/td><\/tr><tr><td width=\"208\"><strong>3:10 pm<\/strong><\/td><td colspan=\"2\" width=\"208\">Strategies to protect the BBB in persons taking anti-amyloid Ab therapy<\/td><td width=\"208\">Katerina Akassoglou<br \/><em>Gladstone Institute, UCSF<\/em><\/td><\/tr><tr><td width=\"208\"><strong>3:30 pm<\/strong><\/td><td colspan=\"2\" width=\"208\">Medin as an Alternative Target for prevention of vascular damage<\/td><td width=\"208\">Jonas J. Neher<br \/><em>German Center for Neurodegenerative Disease, Tubingen<\/em><\/td><\/tr><tr><td width=\"208\"><strong>3:50 pm<\/strong><\/td><td colspan=\"2\" width=\"208\">Protecting endothelial barrier and pericytes with activated protein C mutant: effect of APOE4<\/td><td width=\"208\">Bersilav Zlokovic<br \/><em>USC &#8211; VIRTUAL<\/em><\/td><\/tr><tr><td width=\"208\"><strong>4:10 pm<\/strong><\/td><td colspan=\"2\" width=\"208\"><strong>Panel Discussion<\/strong><br \/><span style=\"text-decoration: underline;\">NIH Moderator:<\/span><br \/>Francesca Bosetti<br \/><em>NINDS<\/em><\/td><td width=\"208\"><span style=\"text-decoration: underline;\">Panelists:<\/span><br \/>John Sims<br \/><em>Ely Lilly<\/em><br \/>Marion Buckwalter<br \/><em>Stanford University<\/em><br \/>Lawrence Honig<br \/><em>Columbia University<\/em><\/td><\/tr><tr><td width=\"208\"><strong>4:50 pm<\/strong><\/td><td colspan=\"2\" width=\"208\"><strong>Day 1 Closing Remarks<\/strong><\/td><td width=\"208\">\u00a0<\/td><\/tr><tr><td width=\"208\"><strong>5:00 pm<\/strong><\/td><td colspan=\"2\" width=\"208\"><strong>Adjourn<\/strong><\/td><td width=\"208\">\u00a0<\/td><\/tr><\/tbody><\/table>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-dc8b808 elementor-widget elementor-widget-heading\" data-id=\"dc8b808\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-large\">DAY 2 - <i>September 29, 2023<\/i><\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-da7c92a elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-mobile elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"da7c92a\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-a4738b7\" data-id=\"a4738b7\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-796c780 elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"796c780\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<table>\n<tbody>\n<tr>\n<td width=\"208\"><strong>Session 3 Future Research Ideas (continued)<\/strong><\/td>\n<td width=\"208\"><strong>Clinical Research Ideas<\/strong>\n<u>Moderators:\u00a0 <\/u>\nAlessandra Rovescalli\n<em>NIA<\/em>\nJohn Detre\n<em>\u00a0 University of Pennsylvania<\/em>\nCynthia Lemere\n<em>Brigham and Women\u2019s Hospital<\/em><\/td>\n<td width=\"208\"><\/td>\n<\/tr>\n<tr>\n<td width=\"208\"><strong>8:30 am<\/strong><\/td>\n<td width=\"208\">Risks associated with cerebrovascular disease comorbidities and their treatments. \u00a0Can anti-beta-amyloid passive immunotherapy be safely combined with anti-thrombotic agents?<\/td>\n<td width=\"208\">Stephen Salloway\n\n<em>\u00a0 Brown<\/em><em> University <\/em><\/td>\n<\/tr>\n<tr>\n<td width=\"208\"><strong>8:50 am<\/strong><\/td>\n<td width=\"208\">How to determine risk of concomitant anti-thrombotic or thrombolytic therapy in persons with CAA.<\/td>\n<td width=\"208\"><em>\u00a0<\/em>Sherry Chou\n\n<em>Northwestern University<\/em><\/td>\n<\/tr>\n<tr>\n<td width=\"208\"><strong>9:10 am<\/strong><\/td>\n<td width=\"208\">Patient stratification: can we identify patients who are not susceptible (or least susceptible) to adverse ARIA events as a result of anti-beta-amyloid passive immunotherapy.<\/td>\n<td width=\"208\">David Knopman\n\n<em>\u00a0 Mayo Clinic<\/em><\/td>\n<\/tr>\n<tr>\n<td width=\"208\"><strong>9:30 am<\/strong><\/td>\n<td width=\"208\">ARIA-E, iatrogenic CAA-ri and the ARIA Paradox. Lessons learned from the last 10 years of biomarkers research and experience on CSF anti-amyloid (auto)antibody testing for ARIA prediction and monitoring.<\/td>\n<td width=\"208\">Fabrizio Piazza\n\n<em>University of Milan-Bicocca<\/em><\/td>\n<\/tr>\n<tr>\n<td width=\"208\"><strong>9:50 am<\/strong><\/td>\n<td width=\"208\">Emerging targets for immunotherapy.<\/td>\n<td width=\"208\">Cynthia Lemere\n\n<em>\u00a0 <\/em><em>Brigham and Women\u2019s <\/em><em>Hospital<\/em><\/td>\n<\/tr>\n<tr>\n<td width=\"208\"><strong>10:10 am<\/strong><\/td>\n<td width=\"208\"><strong>Panel Discussion <\/strong>\n\n<u>Moderator: <\/u>\n\nAlessandra Rovescalli\n\n<em>NIA<\/em><\/td>\n<td width=\"208\"><u>Panelists:<\/u>\n\nScott Turner\n\n<em>Georgetown<\/em><em> University<\/em>\n\nTeresa Buracchio\n\n<em>FDA<\/em>\n\nMaria Carrillo\n\n<em>Alzheimer\u2019s Association<\/em>\n\nHanzhang Lu\n\n<em>Johns<\/em> <em>Hopkins<\/em><em> University<\/em><\/td>\n<\/tr>\n<tr>\n<td width=\"208\"><strong>10:50am <\/strong><\/td>\n<td width=\"208\"><strong>Break<\/strong><\/td>\n<td width=\"208\"><\/td>\n<\/tr>\n<tr>\n<td width=\"208\"><strong>11:00am<\/strong><\/td>\n<td width=\"208\"><strong>Scientific Gaps and Priorities<\/strong><\/td>\n<td width=\"208\"><\/td>\n<\/tr>\n<tr>\n<td width=\"208\"><strong>12:00pm<\/strong><\/td>\n<td width=\"208\"><strong>Conclusion and Final Remarks<\/strong><\/td>\n<td width=\"208\">Richard Hodes\n\n<em>\u00a0NIA<\/em><\/td>\n<\/tr>\n<tr>\n<td width=\"208\"><strong>12:15 pm<\/strong><\/td>\n<td width=\"208\"><strong>Meeting Adjourns<\/strong><\/td>\n<td width=\"208\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2015f6c elementor-widget elementor-widget-spacer\" data-id=\"2015f6c\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-05bbe2a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"05bbe2a\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-a6f20e9\" data-id=\"a6f20e9\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c70ce83 elementor-widget elementor-widget-text-editor\" data-id=\"c70ce83\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<table><tbody><tr style=\"height: 22px;\"><td style=\"height: 22px; width: 208px;\"><strong>Session 3 Future Research Ideas(continued)<\/strong><\/td><td style=\"height: 22px;\"><p><strong>Clinical Research Ideas<br \/><\/strong><span style=\"text-decoration: underline;\">Moderators:<\/span><br \/>Alessandra RovescallI<br \/><em>NIA<\/em><br \/>John Detre<br \/><em>University of Pennsylvania<\/em><br \/>Cynthia Lemere<br \/><em>Brigham and Women\u2019s Hospital<\/em><\/p><\/td><td style=\"height: 22px; width: 25%;\">\u00a0<\/td><\/tr><tr style=\"height: 22px;\"><td style=\"height: 22px;\"><strong>8:30 am<\/strong><\/td><td style=\"height: 22px;\">Risks associated with cerebrovascular disease comorbidities and their treatments. Can anti-beta-amyloid passive immunotherapy be safely combined with anti-thrombotic agents?<\/td><td style=\"height: 22px;\">Stephen Salloway<br \/><em>Brown University<\/em><\/td><\/tr><tr style=\"height: 22.8px;\"><td style=\"height: 22.8px;\"><strong>8:50 am<\/strong><\/td><td style=\"height: 22.8px;\">How to determine risk of concomitant anti-thrombotic or thrombolytic therapy in persons with CAA.<\/td><td style=\"height: 22.8px;\">Sherry Chou<br \/><em>Northwestern University<\/em><\/td><\/tr><tr style=\"height: 22px;\"><td style=\"height: 22px;\"><strong>9:10 am<\/strong><\/td><td style=\"height: 22px;\">Patient stratification: can we identify patients who are not susceptible (or least susceptible) to adverse ARIA events as a result of anti-beta-amyloid passive immunotherapy.<\/td><td style=\"height: 22px;\">David Knopman<br \/><em>Mayo Clinic<\/em><\/td><\/tr><tr style=\"height: 22px;\"><td style=\"height: 22px;\"><strong>9:30 am<\/strong><\/td><td style=\"height: 22px;\">ARIA-E, iatrogenic CAA-ri and the ARIA Paradox. Lessons learned from the last 10 years of biomarkers research and experience on CSF anti-amyloid (auto)antibody testing for ARIA prediction and monitoring.<\/td><td style=\"height: 22px;\">Fabrizio Piazza<br \/><em>University of Milan-Bicocca<\/em><\/td><\/tr><tr style=\"height: 22px;\"><td style=\"height: 22px;\"><strong>9:50 am<\/strong><\/td><td style=\"height: 22px;\">Emerging targets for immunotherapy.<\/td><td style=\"height: 22px;\">Cynthia Lemere<br \/><em>Brigham and Women\u2019s <\/em><br \/><em>Hospital<\/em><\/td><\/tr><tr style=\"height: 22px;\"><td style=\"height: 22px;\"><strong>10:10 am<\/strong><\/td><td style=\"height: 22px;\"><strong>Panel Discussion<\/strong><br \/><span style=\"text-decoration: underline;\">Moderator:<\/span><br \/>Alessandra Rovescalli<br \/><em>NIA<\/em><\/td><td style=\"height: 22px;\"><span style=\"text-decoration: underline;\">Panelists:<\/span><br \/>Scott Turner<br \/><em>Georgetown University<\/em><br \/>Teresa Buracchio<br \/><em>FDA<\/em><br \/>Maria Carrillo<br \/><em>Alzheimer\u2019s Association<\/em><br \/>Hanzhang Lu<br \/><em>Johns Hopkins University<\/em><\/td><\/tr><tr style=\"height: 22px;\"><td style=\"height: 22px;\"><strong>10:50am <\/strong><\/td><td style=\"height: 22px;\"><strong>Break<\/strong><\/td><td style=\"height: 22px;\">\u00a0<\/td><\/tr><tr style=\"height: 22px;\"><td style=\"height: 22px;\"><strong>11:00am<\/strong><\/td><td style=\"height: 22px;\"><strong>Scientific Gaps and Priorities<\/strong><\/td><td style=\"height: 22px;\">\u00a0<\/td><\/tr><tr style=\"height: 22px;\"><td style=\"height: 22px;\"><strong>12:00pm<\/strong><\/td><td style=\"height: 22px;\"><strong>Conclusion and Final Remarks<\/strong><\/td><td style=\"height: 22px;\">Richard Hodes<br \/><em>NIA<\/em><\/td><\/tr><tr style=\"height: 22px;\"><td style=\"height: 22px;\"><strong>12:15 pm<\/strong><\/td><td style=\"height: 22px;\"><strong>Meeting Adjourns<\/strong><\/td><td style=\"height: 22px;\">\u00a0<\/td><\/tr><\/tbody><\/table>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-8414ae0 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"8414ae0\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3e5c76e\" data-id=\"3e5c76e\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c4423a5 elementor-widget elementor-widget-text-editor\" data-id=\"c4423a5\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Goal of Workshop: This NINDS\/NIA sponsored workshop brings together leading experts and researchers from around the world to discuss the latest advancements and challenges in the field of anti-beta amyloid passive immunotherapy. All times are Eastern Standard (EST). Click here to download the printable agenda. DAY 1 &#8211; September 28, 2023 8:30 am Welcome Francesca&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2979","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/event.roseliassociates.com\/antibeta2023\/wp-json\/wp\/v2\/pages\/2979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/event.roseliassociates.com\/antibeta2023\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/event.roseliassociates.com\/antibeta2023\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/antibeta2023\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/event.roseliassociates.com\/antibeta2023\/wp-json\/wp\/v2\/comments?post=2979"}],"version-history":[{"count":584,"href":"https:\/\/event.roseliassociates.com\/antibeta2023\/wp-json\/wp\/v2\/pages\/2979\/revisions"}],"predecessor-version":[{"id":5133,"href":"https:\/\/event.roseliassociates.com\/antibeta2023\/wp-json\/wp\/v2\/pages\/2979\/revisions\/5133"}],"wp:attachment":[{"href":"https:\/\/event.roseliassociates.com\/antibeta2023\/wp-json\/wp\/v2\/media?parent=2979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}